ニュース

BEIJING, AUGUST 24, 2021 - Lepu Medical Technology (Beijing) Co., Ltd. (“Lepu Medical”), a leading global company specialized in developing, manufacturing and marketing high-tech medical devices and equipment, today announced that its 単回使用ラインのための滅菌シリンジ さまざまなCOVID-19ワクチンの送達を含む、一般的な使用のためのCEマーク承認を獲得しました。

CEマークは、Lepu Medicalの単回使用の無菌注射器が、医療専門家が汎用の流体吸引と注射に使用するための安全性と性能に関する欧州連合 (EU) のカテゴリー基準を満たしていることを示しています。これにより、EUおよびその他の地域全体で専門家による購入が可能になります。CEマークを認める国。

Lepu Medical’s 単回使用ラインのための滅菌シリンジ has received CE Mark approval at a time of high-demand for needles suitable to vaccinate populations against the COVID-19 pandemic.  Lepu Medical’s syringe series offers a variety of single-use needles for many applications, including various COVID-19 vaccines. The line includes both Luer Lock and Lock Slip syringes, a clear barrel, plunger, plunger stopper, needle, and cap. Lepu Medical’s syringe series offers a higher resistance to breakage in single-use, and latex-free pistons. The total graduated capacity of all models of syringes is 1mL, with a range of needle sizes to meet a variety of injection and COVID-19 vaccine needs, each distinguished by the color of the needle hub.

Designed to meet a variety of injection needs, Lepu Medical’s Sterile Syringe For Single-Use brings improved safety to patients and doctors with its clear barrel for convenient control of foreign substances. The Sterile Syringe For Single-Use is intended only for one-time use by  healthcare professionals who have received training on medical injection techniques. Injection and vaccine administrators can refer to the Lepu Medical professional manual before use for a full understanding of the device instructions, warnings and precautions.

Lepu Medicalは、単回使用の滅菌注射器に加えて、自己検査用のSARS-CoV-2抗原急速検査キットや医療専門家検査用のSARS-CoV-2抗体検査キットなど、COVID-19の予防と制御のためのさまざまな医薬品を提供しています。 Lepu Medicalは、COVID-19を診断するための標準テストを提供する核酸製品やソリューションなどのCOVID-19診断ソリューション、およびCOVID-19免疫のレベルを監視する抗体テスト製品も提供しています。 Lepu Medicalの他のCOVID-19製品およびソリューションには、サンプル収集キット、手動サンプル抽出キット、自動サンプル抽出器、および標準的な臨床核酸診断用のリアルタイムPCRシステムが含まれます。

As of August 2021, the number of global daily doses of COVID-19 vaccines continues to rise, driving demand for vaccines and vaccination supplies. According to published statistics, by the end of 2020, major governments had placed purchases for over nine billion vaccine units. With the onset of the Delta virus, vaccination rates are ramping up and the expected number of vaccine units is increasing. Government officials and medical professionals across the globe from Israel, France, Germany, the U.S, the United Arab Emirates, Bahrain, the United Kingdom, Switzerland, Cambodia and others are proposing and actively preparing for the third dose of the COVID-19 vaccination to strengthen pandemic prevention and control efforts. With the CE Mark approval for the Sterile Syringe For Single-Use, Lepu Medical will continue to proactively seek qualified partners to support the availability of reliable vaccine supplies across the globe, and assist with COVID-19 management and continuation of general medical practices.